Hot News: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), Caesars Entertainment Corporation (NASDAQ:CZR), Kyocera Corp. (NYSE:KYO), Core Laboratories NV (NYSE:CLB), Equinix, Inc. (NASDAQ:EQIX)

Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) belongs to Healthcare sector. Its weekly performance is 7.12%. On last trading day company shares ended up $12.18. Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) distance from 50-day simple moving average (SMA50) is 6.75%. On 26 May, Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) announced the appointment of Gerald Quirk as General Counsel and Executive Vice President, Business Operations. Mr. Quirk brings to Tokai more than twenty years of experience advancing the legal and business interests of public biopharmaceutical companies, including the development and commercialization of oncology products.

Caesars Entertainment Corporation (NASDAQ:CZR) shares moved down -10.47% in last trading session and ended the day at $6.41. CZR Gross Margin is 51.50% and its return on assets is 18.20%. Caesars Entertainment Corporation (NASDAQ:CZR) quarterly performance is -33.44%. Caesars Entertainment Corporation (NASDAQ:CZR) said that, its Total Rewards Air, the gaming industry’s largest domestic charter service, is enhancing its commercial operation by entering into long-term agreements with Sun Country and Via Airlines.

On 05 June, Kyocera Corp. (NYSE:KYO) shares moved down -0.26% and was closed at $53.44. KYO EPS growth in last 5 year was 23.60%. Kyocera Corp. (NYSE:KYO) year to date (YTD) performance is 16.63%. On 27 May, Kyocera Corp. (NYSE:KYO) said that, it is to collaborate with three project partners on the construction of a 92 MW solar PV project in Japan’s southwestern prefecture of Kagoshima.

Core Laboratories NV (NYSE:CLB) ended the last trading day at $121.55. Company weekly volatility is calculated as 2.90% and price to cash ratio as 272.44. Core Laboratories NV (NYSE:CLB) showed a weekly performance of 3.46%. ING Group downgraded shares of Core Laboratories NV (NYSE:CLB) from a buy rating to a hold rating in a research note released on Thursday morning. They currently have $125.00 target price on the stock, down from their previous target price of $188.00.

Equinix, Inc. (NASDAQ:EQIX) shares remains unchanged in last trading session and ended the day at $263.05. EQIX Gross Margin is 51.80% and its return on assets is -2.90%. Equinix, Inc. (NASDAQ:EQIX) quarterly performance is 13.21%. On 4 June, Equinix, Inc. (NASDAQ:EQIX) has signed an agreement with Aliyun, Alibaba Group Holding Limited’s (NYSE: BABA) cloud computing arm, to provide direct access to Aliyun’s cloud platform via the Equinix Cloud Exchange in Hong Kong and Silicon Valley. The collaboration provides multinational, Chinese, and North American enterprises with dedicated and secure access to the full suite of Aliyun’s cloud services.

Leave a Reply

Your email address will not be published. Required fields are marked *